Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies1,341–1,360 of 20,710
All studies
Nano-sized titanium dioxide exposure induces non-hyperandrogenic polycystic ovarian syndrome in rats by increasing aromatase and apoptosis in granulosa cells.
Data Sheet 1_The triglyceride glucose-body mass index predicts adverse reproductive outcomes in women with polycystic ovary syndrome undergoing frozen embryo transfer.docx
Standardizing anti-müllerian hormone (AMH) and androgen assays: the next Frontier for polycystic ovarian syndrome (PCOS) diagnostic precision.
Correction to: “Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome”
Correction: LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis
Exploring the Pathogenesis of Polycystic Ovary Syndrome Based on Chronic Low-Grade Inflammation
Oocyte-mediated intergenerational transmission of reduced peripheral Th1 cells in polycystic ovary syndrome
The Impact of Melatonin Supplementation on Various Aspects of Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
Data Sheet 1_Global burden of polycystic ovary syndrome, uterine cancer and diabetes mellitus type 2 among women of childbearing age: trends in incidence, prevalence, mortality, and disability-adjusted life-years from 1990 to 2021.pdf
Role of Nutritional Diversity and Lifestyle in Polycystic Ovary Syndrome (PCOS) Risk among College Students: A Cross-Sectional Analysis of Mumbai Metropolitan Region, India
<i>In Vivo</i> Study on the Therapeutic Potential of <i>Nothapodytes nimmoniana</i> (J. Graham) Mabb. in DHEA-induced Polycystic Ovary Syndrome in Female Albino Mice
PREVALENCE OF POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH BODY MASS INDEX VARIATIONS: A SYSTEMATIC REVIEW
Association of Oxidative Stress Biomarkers with Polycystic Ovary Syndrome (PCOS) and Its Metabolic Outcomes, Including Insulin Resistance and Dyslipidemia: A Systematic Review
Evaluation of corin and copeptin as novel biomarkers for polycystic ovary syndrome – diagnostic accuracy and associations with cardiometabolics
Mentha spicata and Its Bioactive Compound Carvone Ameliorate Metabolic Disturbance and Ovarian Dysfunction in Experimental Rat Model of PCOS by Suppression of SREBP1/TLR4-Dependent Pathway.
Reconsidering antral follicle changes in the DHEA-induced PCOS model: the overlooked role of AMH and methodological variability.
Characterisation and evaluation of models of care for polycystic ovary syndrome (PCOS): a multinational study on clinical features, screening practices, and treatment outcomes
Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine
PRESSING CANCEL: INFLUENCE OF STIMULATION PROTOCOL ON CYCLE CANCELLATION (CC) AND OUTCOMES IN POLYCYSTIC OVARY SYNDROME (PCOS) PATIENTS UNDERGOING FRESH IN VITRO FERTILIZATION (IVF) CYCLES
The Predictive Value of Visceral Adiposity Index for Insulin Resistance in Patients with Polycystic Ovary Syndrome